Corcept is leading the way in the research and development of cortisol modulators, molecules that regulate cortisol activity at the glucocorticoid receptor (GR). To date, we have discovered more than 1,000 selective proprietary cortisol modulators.
In 2012, we received FDA approval of Korlym® (mifepristone), the first approved treatment for hypercortisolism (Cushing’s syndrome).
Today, our team and collaborators continue to unlock the possibilities of cortisol modulation as a way to treat serious diseases. With more than 30 ongoing studies across a wide range of disease areas, including endocrinology, oncology, metabolism, and neurology, we remain dedicated to advancing the possibilities of cortisol modulation.
What began as a ripple of scientific truth is now poised to unleash a sea change of discovery representing a fundamental shift in the way we understand and treat disease.
C.T
Corcept Therapeutics is a biopharmaceutical company dedicated to developing innovative treatments for patients affected by hypercortisolism and related disorders. The company focuses on building strong relationships with key opinion leaders across various medical specialties, including endocrinology, cardiology, and nephrology, to enhance the understanding and diagnosis of hypercortisolism. With a commitment to scientific collaboration and advocacy, Corcept Therapeutics aims to expand its market presence through strategic engagement and education initiatives, while adhering to industry regulations and compliance guidelines.
Share This Job!
Save This Job!
Jobs from Corcept Therapeutics:
Director, Patient Safety & PV Compliance, Standards, and Training
Manager, Marketing Operations, Endocrinology Division
Director, Healthcare Professional Marketing
Key Accounts Manager (KAM)
Oncology Medical Science Liaison (MSL)
C.T
Corcept Therapeutics is a biopharmaceutical company dedicated to developing innovative treatments for patients affected by hypercortisolism and related disorders. The company focuses on building strong relationships with key opinion leaders across various medical specialties, including endocrinology, cardiology, and nephrology, to enhance the understanding and diagnosis of hypercortisolism. With a commitment to scientific collaboration and advocacy, Corcept Therapeutics aims to expand its market presence through strategic engagement and education initiatives, while adhering to industry regulations and compliance guidelines.
Share This Job!
Save This Job!
Jobs from Corcept Therapeutics:
Director, Patient Safety & PV Compliance, Standards, and Training
Manager, Marketing Operations, Endocrinology Division
Director, Healthcare Professional Marketing
Key Accounts Manager (KAM)
Oncology Medical Science Liaison (MSL)
C.T
Corcept Therapeutics
The Medical Science Liaison (MSL) will engage with healthcare professionals to promote Corcept's products and support scientific discussions.
C.T
Corcept Therapeutics
The Medical Science Liaison (MSL) will engage with healthcare professionals and thought leaders to promote Corcept's products and support clinical education.
The Medical Science Liaison – Oncology engages with clinicians and organizations to support Natera’s oncology products.
The Medical Science Liaison is responsible for scientific exchange and education regarding ETG products to healthcare professionals.
A.P
Acadia Pharmaceuticals
Acadia Pharmaceuticals is seeking a Medical Science Liaison to support medical initiatives and develop relationships with healthcare practitioners.